Taiwan Purchases 20 Million Additional SpikeVax COVID-19 Vaccines

Massachusetts-based Moderna, Inc. announced today an additional supply agreement with the country of Taiwan for 20 million doses of Moderna’s mRNA COVID-19 (SpikeVax) vaccine and its updated variant booster vaccine candidate if authorized.

These additional vaccines will begin delivery in 2022 and an additional 15 million vaccine doses in 2023.

This new supply agreement is in addition to the February 2021 agreement between Moderna and Taiwan for 5 million vaccine doses in 2021.

Local media reported President Tsai Ing-wen stated on July 21st that 'Taiwan’s COVID-19 vaccine procurement is proceeding as planned, with the country’s inoculation rate expected to reach 25% before the end of the month (July'21).'

On July 22, 2021, the Taiwan Central Epidemic Command Center pointed out that the interval between the first dose and second dose of the Moderna COVID-19 vaccine at this phase was extended to 10-12 weeks for some groups of people on July 12th, and such change was made based on international recommendations. Furthermore, the experts discussed this change at a meeting of the Advisory Committee on Immunization Practices of the Ministry of Health and Welfare.

Previously, the AP reported the U.S. government sent 2.5 million Moderna COVID-19 vaccine doses to Taiwan.